These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12619521)

  • 1. [Caution for false advertising].
    Heinzl S
    Med Monatsschr Pharm; 2003 Feb; 26(2):37. PubMed ID: 12619521
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical advertising versus research spending: are profits more important than patients?
    Mukherjee D; Topol EJ
    Am Heart J; 2003 Oct; 146(4):563-4. PubMed ID: 14564305
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethics of advertising strategies in the pharmaceutical industry.
    Reuter L
    Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 7. Academic Emergency Medicine can print pharmaceutical advertising while not compromising its mission or its integrity.
    Gaddis GM; Olson JE; Wright DW
    Acad Emerg Med; 2009 Oct; 16(10):978-81. PubMed ID: 19799574
    [No Abstract]   [Full Text] [Related]  

  • 8. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies.
    Islam MS; Farah SS
    J Public Health (Oxf); 2007 Jun; 29(2):212-3. PubMed ID: 17513315
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
    Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry--report and recommendations of the Ethics Subcommittee of the International Headache Society.
    Steiner TJ
    Cephalalgia; 2008 Sep; 28 Suppl 3():1-25. PubMed ID: 18666973
    [No Abstract]   [Full Text] [Related]  

  • 12. Misleading drug promotion--no sign of improvements.
    Mansfield PR; Henry D
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):797-9. PubMed ID: 15386716
    [No Abstract]   [Full Text] [Related]  

  • 13. The winner takes it all.
    Walsh K
    J Med Ethics; 2005 May; 31(5):267. PubMed ID: 15863682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Strategies for drug promotion].
    Polonuer JL
    Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
    [No Abstract]   [Full Text] [Related]  

  • 15. Internet marketing of neuroproducts: new practices and healthcare policy challenges.
    Racine E; van der Loos HZ; Illes J
    Camb Q Healthc Ethics; 2007; 16(2):181-94. PubMed ID: 17539470
    [No Abstract]   [Full Text] [Related]  

  • 16. The journal and drug advertising.
    Jureidini J; Mansfield P
    Aust N Z J Psychiatry; 2003 Aug; 37(4):495; discussion 495. PubMed ID: 12873340
    [No Abstract]   [Full Text] [Related]  

  • 17. Big pharma and American psychiatry.
    Sharfstein SS
    J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking issue with "Let's do lunch".
    Gheseger J
    Can Nurse; 2008 Jun; 104(6):5. PubMed ID: 18646296
    [No Abstract]   [Full Text] [Related]  

  • 19. Four drug companies breach industry's code of practice.
    Hawkes N
    BMJ; 2010 Dec; 341():c7266. PubMed ID: 21163846
    [No Abstract]   [Full Text] [Related]  

  • 20. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.